Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04122534
Other study ID # 1111
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 5, 2019
Est. completion date May 15, 2020

Study information

Verified date December 2020
Source Montana State University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This pilot study evaluates a somatic mindfulness training. Reductions in mental and physical health correlates of secondary trauma are assessed using a pretest-posttest design.


Recruitment information / eligibility

Status Completed
Enrollment 48
Est. completion date May 15, 2020
Est. primary completion date May 15, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: - Participant must be either employed or volunteering as a victim service provider, or enrolled at Montana State University as an undergraduate student. Exclusion Criteria: - Participant is under age 18.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Somatic Mindfulness Training
Educational and experiential training to reduce occupational-based secondary trauma.

Locations

Country Name City State
United States Montana State University Bozeman Montana

Sponsors (1)

Lead Sponsor Collaborator
Montana State University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Secondary Traumatic Stress Scale Measures occupational-based secondary traumatic stress using a total scale range of 17(min) to 85 (max). Scores above 37 indicate moderate or higher secondary traumatic stress. This outcome measure will be assessed at week 15.
Secondary Post Traumatic Stress Disorder Checklist for DSM-5 (PCL-5) Measures symptoms of post-traumatic stress disorder using a total scale range of 0 (min) to 80 (max), with a score of 33 or higher indicating that participants maybe suffering from Post Traumatic Stress Disorder. This outcome measure will be assessed at week 15.